Pharmapack Awards 2023

Recognising innovative design of packaging or drug delivery solutions which prioritise patient experience and adherence, for improved health outcomes.

• Design Innovation: Does the entry meet an unmet need, or introduce a new idea, device, method, or novelty to the market? Does it offer a competitive advantage?
• Patient Experience: Does the entry improve patient adherence, safety, experience, and outcomes? Does it reduce dosing errors, is the patient information created with the user in mind, is it readable and accessible for all patients? Is it easy for the patient to recycle the product?
• Ease of Use: Does the entry promote easy and safe administration by patients or HCPs? Is it easy to open and re-seal, is it portable, intuitive, discrete, and ergonomically designed?

Recognising products and solutions which prioritise recyclability, environmental awareness, and a reduced carbon footprint.

• Carbon footprint: Does the product demonstrate a significant decrease to the environmental impact vs other products on the market?
• Sustainability: Is the new product more sustainable or easier to recycle than existing solutions on the market? Does it demonstrate a reduced use of plastic, or if plastics are used, are they chemically compatible or jointly processable during recycling? Are labels and pigments minimized? If the product is composed of several materials, can they be easily separated during recycling processes?

Recognising innovative approaches to safe and efficacious drug administration, including but not limited to; ophthalmic, parenteral, oral, respiratory, transdermal and topical drug delivery solutions.

• Innovation: Does the entry meet an unmet need, or introduce a new idea, device, method or novelty to the market?
• Patient Experience: Does the entry improve patient adherence, experience and outcomes?
• Ease of Use: Does the entry promote easy and safe administration by patients or HCPs?
• Sustainability: Is the product reusable, ecologically designed or easily recyclable?
• Added Value: Does it offer a competitive advantage in the market and within its category? Is it a cost-effective solution? Does it exhibit flexibility, adaptability or a collaborative approach to development?

Recognising innovation in the development of connected devices, IoT applications and wearable technologies, including but not limited to; auto injectors, auto-inhalers, remote monitors (glucose, coagulation etc), wearable defibrillators, early detection devices and EMG sensors.

• Innovation: Does the entry meet an unmet need, or introduce a new idea, device, method or novelty to the market?
• Patient Experience: Does the entry improve patient adherence, experience and outcomes?
• Ease of Use: Does the entry promote easy and safe administration by patients or HCPs?
• Sustainability: Is the entry reusable, ecologically designed or easily recyclable?
• Added Value: Does the entry offer tangible benefits in the collection, monitoring and processing of patient data? Does it offer a competitive advantage in the market and within its category? Is it a cost-effective solution? Does it exhibit flexibility, adaptability or a collaborative approach to development

Recognising innovation in technologies, products, materials, and services relating to primary, secondary and tertiary packaging solutions for finished drug forms which safeguard products from manufacture to point of use. Including, but not limited to; vials, syringes, ampoules, bottles, container liners, flasks, tubes, blister packs, tamper-proof packaging, senior-friendly packaging, child-resistant packaging, and smart packaging.

• Innovation: Does the entry meet an unmet need, or introduce a new idea, device, method or novelty to the market?
• Patient Experience: Does the entry improve patient adherence, experience and outcomes?
• Ease of Use: Does the entry promote easy and safe administration by patients or HCPs?
• Sustainability: Is the entry reusable, ecologically designed or easily recyclable?
• Added Value: Does the entry offer tangible benefits in the collection, monitoring and processing of patient data? Does it offer a competitive advantage in the market and within its category? Is it a cost-effective solution? Does it exhibit flexibility, adaptability?